Literature DB >> 7539757

The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.

M S Choi1, L H Boise, A R Gottschalk, J Quintans, C B Thompson, G G Klaus.   

Abstract

The phenotypically immature B cell lymphoma WEHI-231 undergoes apoptotic cell death when cultured with anti-immunoglobulin (Ig) antibodies, via a bcl-2-independent mechanism. We have therefore studied the role of the bcl-2-related protein bcl-x in controlling cell death in WEHI-231. We find that overexpression of the long form of bcl-x (bcl-XL) renders these cells refractory to anti-Ig-induced cell death. Stimulation of WEHI-231 via CD40 has similar protective effects. We show here that ligation of CD40 rapidly induces the appearance of the bcl-XL protein in WEHI-231, while stimulation via sIgM, sIgD, CD5 or CD45 receptors, or with phorbol esters plus ionomycin does not. WEHI-231 cells also rapidly undergo massive apoptosis following culture with thapsigargin, a specific inhibitor of the Ca(2+)-ATPase of the endoplasmic reticulum: this is also reversed by anti-CD40, or by overexpression of bcl-XL. We, therefore, conclude that bcl-XL plays a key role in the regulation of antigen receptor-mediated apoptosis via CD40 in WEHI-231. In addition, the fact that this protein is not induced in WEHI-231 in response to phorbol dibutyrate plus ionomycin points to a fundamental signaling defect in these cells, which could conceivably be a reflection of their immature, apoptosis-susceptible phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539757     DOI: 10.1002/eji.1830250533

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.

Authors:  Zachary L Pratt; Jingzhu Zhang; Bill Sugden
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 3.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).

Authors:  M Itoh; K Uchimura; N Hayakawa; M Makino; R Hayashi; M Nagata; H Kakizawa; A Nagasaka; H Sakamoto; H Kuzuya
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.

Authors:  B S Chang; A J Minn; S W Muchmore; S W Fesik; C B Thompson
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

Review 6.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

7.  Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.

Authors:  D E Macfarlane; L Manzel; A M Krieg
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

Review 8.  Differentiation and apoptosis of human germinal center B-lymphocytes.

Authors:  Y S Choi
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 9.  Bcl-x and the regulation of survival in the immune system.

Authors:  T W Behrens; D L Mueller
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

10.  The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.

Authors:  Eun-Young Ahn; George Pan; Jae Hwan Oh; Ewan M Tytler; Jay M McDonald
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.